METTL3 and breast cancer: Xu et al. [16] reported that METTL3, together with YTHDF2, reduces large tumor suppressor kinase 1(LTSK1) mRNA stability, thereby promoting the proliferation and glycolytic metabolism in BC through the YAP/TAZ axis and Hippo pathways.